It has been indicated that MMP-9 enhances prostate cancer cell invasion by specifically degrading serpin protease nexin-1 (PN-1) and deregulating the inhibitory effect of PN-1 on urokinase plasminogen activator (uPA) (120). Here, MMP9 is linked to prostate carcinoma.